Cargando…

Apixaban/tocilizumab interaction: Venous thromboembolism: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532484/ http://dx.doi.org/10.1007/s40278-021-04050-5

Ejemplares similares

Apixaban for treatment of venous thromboembolism in an obese patient with Glanzmann thrombasthenia
por: Sattler, Laurent, et al.
Publicado: (2023)

Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021)

Can’t Dissolve Me Now: A COVID-19 Provoked Venous Thromboembolism Breaks Through Apixaban: Case Report
por: Arena, Alexander W., et al.
Publicado: (2021)

Safety of apixaban for venous thromboembolism prophylaxis: the evidence to date
por: Trkulja, Vladimir
Publicado: (2016)

Apixaban for the treatment of cancer-associated venous thromboembolism and left atrial appendage thrombus refractory to optimal anticoagulation with warfarin: a case report
por: Koga, Masashi, et al.
Publicado: (2018)

Medication non‐adherence as a cause of apixaban failure in venous thromboembolism: The importance of pharmacist medication reconciliation
por: Jethwa, Trisha E, et al.
Publicado: (2022)

Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice
por: Hendriks, Stephan V., et al.
Publicado: (2020)

Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery
por: Werth, Sebastian, et al.
Publicado: (2012)

Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
por: Zalpour, Ali, et al.
Publicado: (2014)

Apixaban: Haematochezia: case report
Publicado: (2021)

Development of New Deep Venous Thrombosis While on Apixaban
por: Sharma, Munish, et al.
Publicado: (2017)

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects
por: de Jong, Lisa A., et al.
Publicado: (2018)

Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism
por: Reda, Sara, et al.
Publicado: (2022)

Apixaban: Skin manifestations: case report
Publicado: (2021)

Apixaban: Gastrointestinal bleeding: case report
Publicado: (2021)

Apixaban: Treatment failure: case report
Publicado: (2021)

Case report: apixaban‐induced thrombocytopenia
por: Snellgrove, Oliver
Publicado: (2017)

Apixaban: Lack of efficacy: case report
Publicado: (2022)

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
por: Cohen, Alexander, et al.
Publicado: (2021)

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease
por: Cohen, Alexander T., et al.
Publicado: (2021)

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
por: Cornell, Robert Frank, et al.
Publicado: (2019)

Eosinophilia complicated with venous thromboembolism: A case report
por: Su, Wei-Qiang, et al.
Publicado: (2022)

Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways
por: Huppertz, Andrea, et al.
Publicado: (2019)

Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
por: Beyer-Westendorf, Jan, et al.
Publicado: (2021)

Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
por: Weycker, Derek, et al.
Publicado: (2018)

Population Pharmacokinetics, Pharmacodynamics, and Exploratory Exposure–Response Analyses of Apixaban in Subjects Treated for Venous Thromboembolism
por: Byon, W, et al.
Publicado: (2017)

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
por: Cohen, Alexander T., et al.
Publicado: (2022)

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
por: Cohen, Alexander T., et al.
Publicado: (2023)

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
por: Caroti, Kimberly Snow, et al.
Publicado: (2023)

Apixaban/enoxaparin sodium: Lack of efficacy: case report
Publicado: (2021)

Apixaban/heparin/warfarin: Treatment failure: case report
Publicado: (2021)

Postpartum prophylaxis of venous thromboembolism with anticoagulation: A case report
por: Mohzari, Yahya A., et al.
Publicado: (2021)

Multiple drugs: Venous thromboembolism and lack of efficacy: case report
Publicado: (2021)

Elasomeran/raloxifene: Acute venous thromboembolism: 3 case reports
Publicado: (2022)

Case Report: Unprovoked venous thromboembolism in a young adult male
por: Dhabhar, Jeyhan, et al.
Publicado: (2019)

Venous thromboembolism and COVID-19: a case report and review of the literature
por: Bhatt, Harshil, et al.
Publicado: (2020)

Spontaneous splenic rupture associated with apixaban: a case report
por: Lowry, Lacy E., et al.
Publicado: (2016)

Carbamazepine Induction Impacting Apixaban Concentrations: A Case Report
por: Bungard, Tammy J., et al.
Publicado: (2020)

Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
Publicado: (2020)

A rare case report of apixaban-induced lichenoid eruption
por: Patil, Tanvi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_age9p7qtn2737uhr2608irsffc